AI Tool Developed to Predict Risk of hsPDA in Extremely Premature Infants

A recent study published in *Pediatric Research* details the development of a machine learning tool designed to predict the risk of hemodynamically significant patent ductus arteriosus (hsPDA) in extremely premature infants. The condition, which involves the failure of a fetal blood vessel to close after birth, can lead to severe complications such as heart failure and other life-threatening issues. Researchers have created an artificial intelligence model aimed at identifying infants most at risk for hsPDA, potentially enabling earlier intervention and improved outcomes.

The study highlights how this AI-driven approach analyzes clinical data from premature newborns to assess their likelihood of developing hsPDA. By leveraging patterns within medical records and patient information, the tool provides clinicians with predictive insights that could guide treatment decisions. This advancement represents a step forward in neonatal care by addressing one of the critical challenges faced by healthcare providers managing preterm births.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: October 29, 2025

Related posts:

Webinar on Nitrosamines Analysis Scheduled for June 26, 2025, to Address Method Development and Practical Applications Study Explores Variations in Demographics and Health Profiles of Dual-Eligible Beneficiaries Across Medicare Advantage Plans National Academies Report Proposes 53 Recommendations to Simplify Research Regulations and Reduce Administrative Burdens NAVER D2SF Invests in GravityLabs to Support Expansion into CRO Sector

Author

GOAI